Variable | Median Overall Survival(m) | 95%CI | P value |
---|---|---|---|
Age(y) | 0.066 | ||
< 60 | 27 | 19.0–34.9 | |
≥ 60 | 38 | 23.2–52.8 | |
Gender | 0.824 | ||
Male | 31 | 19.8–42.2 | |
Female | 30 | 16.4–43.6 | |
Smoking history | 0.422 | ||
Yes | 26 | 17.2–34.8 | |
No | 35 | 22.7–47.3 | |
Structural components | 0.031 | ||
AC-Predominant | 35 | 25.6–44.4 | |
SCC-Predominant | 24 | 12.4–35.6 | |
Tumor location | 0.011 | ||
Peripheral | 35 | 27.9–42.1 | |
Central | 23 | 10.5–35.5 | |
T-stage | 0.115 | ||
T1 | 38 | 24.2–51.8 | |
T2 | 34 | 28.8–39.2 | |
T3 | 23 | 15.6–30.3 | |
N-stage | 0.238 | ||
N0 | 31 | 5.7–56.3 | |
N1 | 24 | 19.2–28.8 | |
N2 | 37 | 30.8–43.2 | |
TNM-stage | 0.103 | ||
I | 46 | 21.2–70.8 | |
II | 26 | 19.8–32.2 | |
IIIA | 32 | 20.9–43.0 |